ESSA Pharma Inc.
ESSA Pharma Inc. (EPIX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
epix · pe ratio · data through Sep 30, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for ESSA Pharma Inc. (EPIX) measures how much investors pay for each dollar of the company's trailing earnings. EPIX's current PE ratio of N/A is calculated by dividing its stock price of $0.20 by its TTM earnings per share of -$0.43.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-09-30
PE Ratio History
2012 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
ESSA Pharma Inc.You EPIX | $10M | N/A | — | -$0.43 |
 Apexigen, Inc. APGN | $10M | N/A | — | -$1.59 |
 Biora Therapeutics, Inc. BIOR | $1M | N/A | — | -$78.69 |
 Channel Therapeutics Corporation CHRO | $9M | N/A | — | -$2.30 |
 CervoMed Inc. CRVO | $27M | N/A | — | -$2.98 |
 COSCIENS Biopharma Inc. CSCI | $9M | N/A | — | -$5.93 |
 IMV Inc. IMVIF | $0M | N/A | — | -$4.37 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-09-30Latest FY2024 | — | $-0.64 | — | |
2023-09-30 FY2023 | — | $-0.60 | — | |
2022-09-30 FY2022 | — | $-0.80 | — | |
2021-09-30 FY2021 | — | $-0.96 | — | |
2020-09-30 FY2020 | — | $-1.04 | — | |
2019-09-30 FY2019 | — | $-1.24 | — | |
2018-09-30 FY2018 | — | $-2.55 | — | |
2017-09-30 FY2017 | — | $-3.09 | — | |
2016-09-30 FY2016 | — | $-9.77 | — | |
2015-09-30 FY2015 | — | $-9.34 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for ESSA Pharma Inc. (EPIX) measures how much investors pay for each dollar of the company's trailing earnings. EPIX's current PE ratio of N/A is calculated by dividing its stock price of $0.20 by its TTM earnings per share of -$0.43.
Frequently asked questions
EPIX pe ratio · 6 questionsEPIX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.20 and TTM EPS of -$0.43. Data sourced from Financial Modeling Prep via EPIX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ESSA Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09